Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis

Satheesh K. Sainathan, Eyad M. Hanna, Qingging Gong, Kumar S. Bishnupuri, Qizhi Luo, Marco Colonna, Frances V. White, Ed Croze, Courtney Houchen, Shrikant Anant, Brian K. Dieckgraefe

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Abstract

Background: Sargramostim, granulocyte macrophage colony-stimulating factor (GM-CSF), a hematopoietic growth factor, stimulates cells of the intestinal innate immune system. Clinical trials show that sargramostim induces clinical response and remission in patients with active Crohn's disease. To study the mechanism, we examined the effects of GM-CSF in the dextran sulfate sodium (DSS)-induced acute colitis model. We hypothesized that GM-CSF may work through effects on dendritic cells (DCs). Methods: Acute colitis was induced in Balb/c mice by administration of DSS in drinking water. Mice were treated with daily GM-CSF or phosphate-buffered saline (PBS). To probe the role of plasmacytoid DCs (pDCs) in the response to GM-CSF, we further examined the effects of monoclonal antibody 440c, which is specific for a sialic acid-binding immunoglobulin (Ig)-like lectin expressed on pDCs. Results: GM-CSF ameliorates acute DSS-induced colitis, resulting in significantly improved clinical parameters and histology. Microarray analysis showed reduced expression of proinflammatory genes including TNF-α and ILI-β; the results were further confirmed by real-time reverse-transcriptase polymerase chain reaction and serum Bio-plex analysis. GM-CSF treatment significantly expands pDCs and type 1 IFN production. Administration of mAb 440c completely blocked the therapeutic effect of GM-CSF. GM-CSF is also effective in RAG1-/- mice, demonstrating activity-independent effects on T and B cells. IFN-β administration mimics the therapeutic effect of GM-CSF in DSS-treated mice. GM-CSF increases systemic and mucosal type 1 IFN expression and exhibits synergy with pDC activators, such as microbial cytosine-phosphate-guanosine (CpG) DNA. Conclusions: GM-CSF is effective in the treatment of DSS colitis in a mechanism involving the 440c + pDC population.

Original languageEnglish
Pages (from-to)88-99
Number of pages12
JournalInflammatory bowel diseases
Volume14
Issue number1
DOIs
StatePublished - Jan 2008

Keywords

  • DSS
  • Dextran sulfate sodium
  • GM-CSF
  • Granulocyte macrophage colony-stimulating factor
  • Sargramostim

Fingerprint

Dive into the research topics of 'Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis'. Together they form a unique fingerprint.

Cite this